Viewing Study NCT05033132


Ignite Creation Date: 2025-12-24 @ 10:01 PM
Ignite Modification Date: 2025-12-31 @ 2:30 AM
Study NCT ID: NCT05033132
Status: WITHDRAWN
Last Update Posted: 2024-03-28
First Post: 2021-08-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Study of Balstilimab Independently or in Combination With Zalifrelimab in Advanced Cervical Cancer
Sponsor: Agenus Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module